BJ HEALTH (02389) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of HK$76.587 million, representing a 4.47% year-on-year increase. Loss attributable to owners of the parent company was HK$29.236 million, down 48.17% compared to the same period last year. Basic loss per share stood at HK$0.48 cents.

According to the announcement, the revenue increase was primarily driven by moderate growth in both medical and elderly care product sales and elderly care business revenue. The medical and elderly care products segment's revenue growth was mainly attributed to the group's earlier expansion into new educational furniture product lines, which has proven effective with continued annual sales growth sufficient to offset the decline in hospital furniture and elderly care furniture sales. Educational furniture customers are primarily domestic universities and colleges, providing strong cash flow and lower bad debt risk.

The increase in elderly care business revenue was mainly due to higher occupancy rates.